新闻
2024-07-03
全球首批!FDA批准礼来阿尔茨海默病疗法
临床结果上市批准
2024-07-03
重磅!罗欣药业注射用LX22001获批开展临床试验
临床3期申请上市
2024-07-03
一针管半年!礼来长效RNAi疗法在中国启动3期临床,针对心血管疾病
临床结果siRNA信使RNA
2024-07-03
创新药枸橼酸倍维巴肽注射液获批上市
上市批准
2024-07-02
Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
免疫疗法引进/卖出
2024-07-02
治疗乳腺癌脑转移,华昊中天「优替德隆」获FDA批准2期临床试验
ASCO会议临床2期临床结果抗体药物偶联物
2024-07-02
海创药业口服PROTAC药物获FDA授予快速通道认定,治疗乳腺癌
蛋白降解靶向嵌合体临床结果
2024-07-02
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
上市批准引进/卖出免疫疗法
2024-07-02
每月一次!罗氏新一代抗体疗法获积极监管决定
临床结果临床成功
2024-07-02
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
临床2期